Clinical Chemistry, Malmö
251 – 260 of 1293
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays.
(
- Contribution to journal › Article
-
Mark
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.
(
- Contribution to journal › Article
-
Mark
A protein deep sequencing evaluation of metastatic melanoma tissues.
(
- Contribution to journal › Article
-
Mark
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
(
- Contribution to journal › Article
-
Mark
A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Perioperative changes in PIVKA-II
(
- Contribution to journal › Article
-
Mark
Comparison of automated von Willebrand factor activity assays.
2015) In Thrombosis Research(
- Contribution to journal › Article
-
Mark
Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.
2015) In Oncotarget(
- Contribution to journal › Article
-
Mark
A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.
2015) In European Urology(
- Contribution to journal › Article
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
(
- Contribution to journal › Article